Topiramate: Smoking Cessation

2008 ◽  
Vol 43 (10) ◽  
pp. 805-806
Author(s):  
Joyce A. Generali ◽  
Dennis J. Cada
Keyword(s):  
Health Care ◽  
Smoking Cessation ◽  
Patient Care ◽  
Patient Population ◽  
Hospital Pharmacy ◽  
Specific Drug ◽  
Off Label ◽  
Comprehensive Information ◽  
The Us ◽  
Therapeutic Considerations

Off-Label Drug Uses — This Hospital Pharmacy feature is extracted from Off-Label DrugFacts, a quarterly publication available from Wolters Kluwer Health. Off-Label DrugFacts is a practitioner-oriented resource for information about specific drug uses that are unapproved by the US Food and Drug Administration (FDA). This new guide to the literature will enable the health care professional or clinician to quickly identify published studies on off-label uses and determine if a specific use is rational in a patient care scenario. A summary of the most relevant data is provided, including background, study design, patient population, dosage information, therapy duration, results, safety, and therapeutic considerations. References direct the reader to the full literature for more comprehensive information before patient care decisions are made. Direct questions or comments regarding Off-Label Drug Uses to [email protected] .

Ondansetron: Cholestatic Pruritus (Adults)

2009 ◽  
Vol 44 (10) ◽  
pp. 868-869
Author(s):  
Joyce A. Generali ◽  
Dennis J. Cada
Keyword(s):  
Health Care ◽  
Patient Care ◽  
Health Care Professional ◽  
Patient Population ◽  
Hospital Pharmacy ◽  
Specific Drug ◽  
Off Label ◽  
Comprehensive Information ◽  
The Us ◽  
Therapeutic Considerations

This Hospital Pharmacy feature is extracted from Off-Label Drug Facts, a quarterly publication available from Wolters Kluwer Health. Off-Label Drug Facts is a practitioner-oriented resource for information about specific drug uses that are unapproved by the US Food and Drug Administration. This new guide to the literature enables the health care professional or clinician to quickly identify published studies on off-label uses and determine if a specific use is rational in a patient care scenario. A summary of the most relevant data is provided, including background, study design, patient population, dosage information, therapy duration, results, safety, and therapeutic considerations. References direct the reader to the full literature for more comprehensive information before patient care decisions are made. Direct questions or comments regarding Off-Label Drug Uses to hospital [email protected] .

Nicotine (Transdermal): Ulcerative Colitis

2009 ◽  
Vol 44 (4) ◽  
pp. 309-310
Author(s):  
Joyce A. Generali ◽  
Dennis J. Cada
Keyword(s):  
Ulcerative Colitis ◽  
Health Care ◽  
Patient Care ◽  
Patient Population ◽  
Hospital Pharmacy ◽  
Specific Drug ◽  
Off Label ◽  
Comprehensive Information ◽  
The Us ◽  
Therapeutic Considerations

This Hospital Pharmacy feature is extracted from Off-Label Drug Facts, a quarterly publication available from Wolters Kluwer Health. Off-Label Drug Facts is a practitioner-oriented resource for information about specific drug uses that are unapproved by the US Food and Drug Administration. This new guide to the literature will enable the health care professional or clinician to quickly identify published studies on off-label uses and determine if a specific use is rational in a patient care scenario. A summary of the most relevant data is provided, including background, study design, patient population, dosage information, therapy duration, results, safety, and therapeutic considerations. References direct the reader to the full literature for more comprehensive information before patient care decisions are made. Direct questions or comments regarding Off-Label Drug Uses to hospital [email protected] .

Amantadine: Postpoliomyelitis Syndrome—Related Fatigue

2008 ◽  
Vol 43 (11) ◽  
pp. 884-885
Author(s):  
Joyce A. Generali ◽  
Dennis J. Cada
Keyword(s):  
Health Care ◽  
Patient Care ◽  
Health Care Professional ◽  
Patient Population ◽  
Hospital Pharmacy ◽  
Specific Drug ◽  
Off Label ◽  
Comprehensive Information ◽  
The Us ◽  
Therapeutic Considerations

Off-Label Drug Uses — This Hospital Pharmacy feature is extracted from Off-Label Drug Facts, a quarterly publication available from Wolters Kluwer Health. Off-Label Drug Facts is a practitioner-oriented resource for information about specific drug uses that are unapproved by the US Food and Drug Administration (FDA). This new guide to the literature will enable the health care professional or clinician to quickly identify published studies on off-label uses and determine if a specific use is rational in a patient care scenario. A summary of the most relevant data is provided, including background, study design, patient population, dosage information, therapy duration, results, safety, and therapeutic considerations. References direct the reader to the full literature for more comprehensive information before patient care decisions are made. Direct questions or comments regarding Off-Label Drug Uses to [email protected] .

Ondansetron: Tardive Dyskinesia

2010 ◽  
Vol 45 (4) ◽  
pp. 301-302
Author(s):  
Joyce A. Generali ◽  
Dennis J. Cada
Keyword(s):  
Health Care ◽  
Tardive Dyskinesia ◽  
Patient Care ◽  
Patient Population ◽  
Hospital Pharmacy ◽  
Specific Drug ◽  
Off Label ◽  
Comprehensive Information ◽  
The Us ◽  
Therapeutic Considerations

This Hospital Pharmacy feature is extracted from Off-Label Drug Facts, a quarterly publication available from Wolters Kluwer Health. Off-Label Drug Facts is a practitioner-oriented resource for information about specific drug uses that are unapproved by the US Food and Drug Administration. This new guide to the literature enables the health care professional or clinician to quickly identify published studies on off-label uses and determine if a specific use is rational in a patient care scenario. A summary of the most relevant data is provided, including background, study design, patient population, dosage information, therapy duration, results, safety, and therapeutic considerations. References direct the reader to the full literature for more comprehensive information before patient care decisions are made. Direct questions or comments regarding Off-Label Drug Uses to [email protected] .

Ondansetron: Postanesthetic Shivering

2009 ◽  
Vol 44 (8) ◽  
pp. 670-671 ◽  
Author(s):  
Joyce A. Generali ◽  
Dennis J. Cada
Keyword(s):  
Health Care ◽  
Patient Care ◽  
Patient Population ◽  
Hospital Pharmacy ◽  
Specific Drug ◽  
Off Label ◽  
Comprehensive Information ◽  
Postanesthetic Shivering ◽  
The Us ◽  
Therapeutic Considerations

This Hospital Pharmacy feature is extracted from Off-Label Drug Facts, a quarterly publication available from Wolters Kluwer Health. Off-Label Drug Facts is a practitioner-oriented resource for information about specific drug uses that are unapproved by the US Food and Drug Administration. This new guide to the literature enables the health care professional or clinician to quickly identify published studies on off-label uses and determine if a specific use is rational in a patient care scenario. A summary of the most relevant data is provided, including background, study design, patient population, dosage information, therapy duration, results, safety, and therapeutic considerations. References direct the reader to the full literature for more comprehensive information before patient care decisions are made. Direct questions or comments regarding Off-Label Drug Uses to hospital [email protected] .

Thyroxine: Once-Weekly Administration for Hypothyroidism

2009 ◽  
Vol 44 (9) ◽  
pp. 748-749
Author(s):  
Joyce A. Generali ◽  
Dennis J. Cada
Keyword(s):  
Health Care ◽  
Patient Care ◽  
Patient Population ◽  
Hospital Pharmacy ◽  
Specific Drug ◽  
Weekly Administration ◽  
Off Label ◽  
Comprehensive Information ◽  
The Us ◽  
Therapeutic Considerations

This Hospital Pharmacy feature is extracted from Off-Label Drug Facts, a quarterly publication available from Wolters Kluwer Health. Off-Label Drug Facts is a practitioner-oriented resource for information about specific drug uses that are unapproved by the US Food and Drug Administration. This new guide to the literature enables the health care professional or clinician to quickly identify published studies on off-label uses and determine if a specific use is rational in a patient care scenario. A summary of the most relevant data is provided, including background, study design, patient population, dosage information, therapy duration, results, safety, and therapeutic considerations. References direct the reader to the full literature for more comprehensive information before patient care decisions are made. Direct questions or comments regarding Off-Label Drug Uses to hospital [email protected] .

Levetiracetam: Rapid-Cycling Bipolar Disorder (Adults)

2009 ◽  
Vol 44 (5) ◽  
pp. 390-391
Author(s):  
Joyce A. Generali ◽  
Dennis J. Cada
Keyword(s):  
Health Care ◽  
Bipolar Disorder ◽  
Patient Care ◽  
Hospital Pharmacy ◽  
Specific Drug ◽  
Rapid Cycling ◽  
Off Label ◽  
Comprehensive Information ◽  
The Us ◽  
Therapeutic Considerations

This Hospital Pharmacy feature is extracted from Off-Label Drug Facts, a quarterly publication available from Wolters Kluwer Health. Off-Label Drug Facts is a practitioner-oriented resource for information about specific drug uses that are unapproved by the US Food and Drug Administration. This new guide to the literature enables the health care professional or clinician to quickly identify published studies on off-label uses and determine if a specific use is rational in a patient care scenario. A summary of the most relevant data is provided, including background, study design, patient population, dosage information, therapy duration, results, safety, and therapeutic considerations. References direct the reader to the full literature for more comprehensive information before patient care decisions are made. Direct questions or comments regarding Off-Label Drug Uses to hospital [email protected] .

Topiramate: Smoking Cessation

2007 ◽  
Vol 42 (10) ◽  
pp. 910-913
Author(s):  
Joyce Generali ◽  
Dennis J. Cada
Keyword(s):  
Health Care ◽  
Smoking Cessation ◽  
Patient Care ◽  
Health Care Professional ◽  
Patient Population ◽  
Hospital Pharmacy ◽  
Tabular Form ◽  
Off Label ◽  
Comprehensive Information ◽  
Therapeutic Considerations

Off-Label Drug Uses — This Hospital Pharmacy feature is extracted from Off-Label DrugFacts, a quarterly publication available from Wolters Kluwer Health. Off-Label DrugFacts is a practitioner-oriented resource for information about specific FDA-unapproved drug uses. This new guide to the literature will enable the health care professional/clinician to quickly identify published studies on off-label uses and to determine if a specific use is rational in a patient care scenario. The most relevant data are provided in tabular form, so the reader can easily identify the scope of information available. A summary of the data—including background, study design, patient population, dosage information, therapy duration, results, safety, and therapeutic considerations—precedes each table of published studies. References direct the reader to the full literature for more comprehensive information prior to patient care decisions. Direct questions or comments regarding “Off-Label Drug Uses” to [email protected] .

Atorvastatin: Rheumatoid Arthritis

2005 ◽  
Vol 40 (2) ◽  
pp. 144-183
Author(s):  
Joyce Generali ◽  
Dennis J. Cada
Keyword(s):  
Rheumatoid Arthritis ◽  
Health Care ◽  
Patient Care ◽  
Health Care Professional ◽  
Patient Population ◽  
Hospital Pharmacy ◽  
Tabular Form ◽  
Off Label ◽  
Comprehensive Information ◽  
Therapeutic Considerations

Off-Label Drug Uses This Hospital Pharmacy feature is extracted from Off-Label DrugFacts, a quarterly publication available from Facts and Comparisons. Off-Label DrugFacts is a practitioner-oriented resource for information about specific FDA-unapproved drug uses. This new guide to the literature will enable the health care professional/clinician to quickly identify published studies on off-label uses and to determine if a specific use is rational in a patient care scenario. The most relevant data are provided in tabular form so that the reader can easily identify the scope of information available. A summary of the data—including background, study design, patient population, dosage information, therapy duration, results, safety, and therapeutic considerations—precedes each table of published studies. References direct the reader to the full literature for more comprehensive information prior to patient care decisions. Direct questions or comments on “Off-Label Drug Uses” to [email protected] .

Gabapentin: Hyperhidrosis

2003 ◽  
Vol 38 (1) ◽  
pp. 25-26
Author(s):  
Joyce Generali ◽  
Dennis J. Cada
Keyword(s):  
Health Care ◽  
Patient Care ◽  
Health Care Professional ◽  
Study Design ◽  
Patient Population ◽  
Hospital Pharmacy ◽  
Tabular Form ◽  
Off Label ◽  
Comprehensive Information ◽  
Therapeutic Considerations

Off-Label Drug Uses This Hospital Pharmacy feature is extracted from Off-Label DrugFacts, a quarterly publication available from Facts and Comparisons. Off-Label DrugFacts is a practitioner-oriented resource for information about specific FDA-unapproved drug uses. This new guide to the literature will enable the health care professional/clinician to quickly identify published studies on off-label uses and to determine if a specific use is rational in a patient care scenario. The most relevant data are provided in tabular form so that the reader can easily identify the scope of information available. A summary of the data—including, background, study design, patient population, dosage information, therapy duration, results, safety, and therapeutic considerations—precedes each table of published studies. References direct the reader to the full literature for more comprehensive information prior to patient care decisions. Direct questions or comments on “Off-Label Drug Uses” to [email protected] .

Sign in / Sign up

Export Citation Format

Share Document